The importance of immediate verification of a cervical cytological abnormality with histology

2013 ◽  
Vol 50 (4) ◽  
pp. 292 ◽  
Author(s):  
C Kabaca ◽  
B Sariibrahim ◽  
I Keleli ◽  
A Karateke ◽  
S Cesur ◽  
...  
1993 ◽  
Vol 48 (9) ◽  
pp. 619-620
Author(s):  
M. P. M. Burger ◽  
H. Hollema ◽  
A. S. H. Gouw ◽  
W. J. L. M. Pieters ◽  
W. G. V. Quint

BMJ ◽  
1993 ◽  
Vol 306 (6880) ◽  
pp. 749-752 ◽  
Author(s):  
M P Burger ◽  
H Hollema ◽  
A S Gouw ◽  
W J Pieters ◽  
W G Quint

2018 ◽  
Vol 26 (2) ◽  
pp. 104-112
Author(s):  
Ming Li ◽  
David Roder ◽  
Lisa J Whop ◽  
Abbey Diaz ◽  
Peter D Baade ◽  
...  

Objective Cervical cancer mortality has halved in Australia since the national cervical screening program began in 1991, but elevated mortality rates persist for Aboriginal and Torres Strait Islander women (referred to as Aboriginal women in this report). We investigated differences by Aboriginal status in abnormality rates predicted by cervical cytology and confirmed by histological diagnoses among screened women. Methods Using record linkage between cervical screening registry and public hospital records in South Australia, we obtained Aboriginal status of women aged 20–69 for 1993–2016 (this was not recorded by the registry). Differences in cytological abnormalities were investigated by Aboriginal status, using relative risk ratios from mixed effect multinomial logistic regression modelling. Odds ratios were calculated for histological high grade results for Aboriginal compared with non-Aboriginal women. Results Of 1,676,141 linkable cytology tests, 5.8% were abnormal. Abnormal results were more common for women who were younger, never married, and living in a major city or socioeconomically disadvantaged area. After adjusting for these factors and numbers of screening episodes, the relative risk of a low grade cytological abnormality compared with a normal test was 14% (95% confidence interval 5–24%) higher, and the relative risk of a high grade cytological abnormality was 61% (95% confidence interval 44–79%) higher, for Aboriginal women. The adjusted odds ratio of a histological high grade was 76% (95% confidence interval 46–113%) higher. Conclusions Ensuring that screen-detected abnormalities are followed up in a timely way by culturally acceptable services is important for reducing differences in cervical cancer rates between Aboriginal and non-Aboriginal women.


Sexual Health ◽  
2013 ◽  
Vol 10 (6) ◽  
pp. 587
Author(s):  
Jennifer Roberts ◽  
Clare Biro ◽  
Annabelle Farnsworth ◽  
Debbie Ekman ◽  
Marjorie Adams ◽  
...  

Background Anal cytology may form the basis of a future screening program to prevent anal carcinoma. Therefore, the accuracy of anal Papanicolaou tests in detecting histological HSIL needs to be evaluated. Methods: SPANC is a 3-year prospective study in homosexual men aged ≥35 years. At each of five visits, men undergo collection of a ThinPrep® anal cytological sample, high-resolution anoscopy (HRA) and biopsy of any abnormalities. Cytology is reported using the Bethesda system. Histology is reported using lower anogenital squamous terminology. Results: 351 men had a baseline visit by end July 2013. Median age was 49 (range: 35–79) years and 101 (28.8%) men were HIV positive. Anal cytology results were: unsatisfactory in 21 (6.0%), negative in 143 (40.7%), ASC-US in 51 (14.5%), LSIL in 22 (6.3%), ASC-H in 45 (12.8%) and HSIL in 69 (19.7%). 293 of 351 (83.5%) men had baseline histology. The most severe abnormality for each was: negative for SIL in 98 (33.4%), LSIL in 87 (29.7%) and HSIL in 108 (36.9%). Anal cytology sensitivity for histological HSIL (at ASC-US threshold) was 79.0%. Specificity was 53.8%. Positive predictive value (PPV) of any cytological abnormality for histological HSIL was 44.4% and PPV of HSIL cytoprediction was 63.8%. Negative predictive value (NPV) was 84.6%. Overall there was no significant difference between HIV positive and negative men with respect to sensitivity, specificity, PPV or NPV. Conclusions: These results indicate that histological HSIL is common in homosexual men. The finding of any cytological abnormality should prompt HRA. However, both cytology and HRA can miss or underestimate significant lesions in a single screening.


1932 ◽  
Vol 26 (3) ◽  
pp. 341-344 ◽  
Author(s):  
J. B. S. Haldane

Author(s):  
Asan Ali Qasim Al Niyazee ◽  
Sarab K. Abedalrahman ◽  
Luma Abdulrazzaq Mohammed Saleh

2016 ◽  
Vol 60 (3) ◽  
pp. 211-216
Author(s):  
Hernán Vargas ◽  
Jenny P. Sánchez ◽  
Mónica L. Guerrero ◽  
Leider T. Ortiz ◽  
Dayanne M. Rodríguez ◽  
...  

Objectives: To estimate the frequency of human papillomavirus (HPV) infection and the genotype distribution of HPV among women with a Pap smear showing atypical squamous cells of undetermined significance (ASC-US) attending the Program for the Detection and Control of Cervical Cancer in Bogotá, Colombia. Study Design: Cervical samples from 200 women with an ASC-US Pap smear were analyzed for the presence of HPV DNA and genotype distribution using a commercial molecular technique (Linear Array®; Roche Molecular Systems, USA). Results: HPV infection was found in 140 women (70%). High-risk HPV types were present in 46.4% of the samples; 16.4% showed a low-risk HPV type, and 37.1% showed both. Of the positive samples, 42.9% were infected with a single viral genotype, whereas 57.1% exhibited multiple HPV infections. The most common HPV genotypes were HPV 16, 53, and 52 with a prevalence of 26.4, 16.4, and 13.6%, respectively. Conclusion: The epidemiological characterization of HPV infections described in this study might guide actions for epidemiological surveillance to strengthen the program in Bogotá and to develop appropriate HPV vaccination programs.


1993 ◽  
Vol 4 (5) ◽  
pp. 297-299 ◽  
Author(s):  
S M Young ◽  
R M Malet

A retrospective study compared one year's cervical smear results from 4920 women from the following 3 populations in Leicestershire; the Genitourinary Medicine (GUM) Departments; the city family planning clinic (FPC); and a general practice (GP) in a local University town. The results were standardized for age by logistic regression. Cytological abnormality was divided into: dyskaryosis (all grades), borderline, and inflammatory changes. The GUM attenders had an excess of total cervical smear abnormalities compared to both the FPC ( P<0.001) and GP population ( P<0.001) after adjusting for age. The FPC and GP rates of smear abnormality were similar at 60 and 63 per 1000 women screened, respectively, while the rate for the GUM clinic was 155 per 1000 women screened.


Sign in / Sign up

Export Citation Format

Share Document